Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia Biotech Investing
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD Pharmaceutical Investing
Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid Pharmaceutical Investing
Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Pharmaceutical Investing
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study Life Science Investing
Theratechnologies Announces Financial Results for the Second Quarter of 2018 Pharmaceutical Investing
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval Pharmaceutical Investing
